Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Specials
Spring Home & Garden Show
Home & Realty
Outdoor Guide
Women
Spring on the Road
Spring Wellness
Premier Home Stylle Tour 2024
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
2024 Readersâ Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Biontech Se ADR
(NQ:
BNTX
)
84.46
-2.79 (-3.20%)
Streaming Delayed Price
Updated: 12:53 PM EDT, Aug 16, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Biontech Se ADR
< Previous
1
2
3
4
5
6
7
8
9
...
54
55
Next >
5 Value Stocks To Watch In The Healthcare Sector
August 28, 2023
Via
Benzinga
Expert Ratings for BioNTech
August 28, 2023
Via
Benzinga
COVID Is Making a Comeback: Should You Buy These 2 Stocks?
August 27, 2023
Can these companies keep up their recent momentum?
Via
The Motley Fool
Exposures
COVID-19
Novavax (NVAX) Stock Is Getting Ready to Rally Again
August 22, 2023
Novavax only has an Emergency Use Authorization and faces a struggle to get paid for its protein-based Covid shot.
Via
InvestorPlace
Exposures
COVID-19
Why Moderna, BioNTech SE, and Novavax Surged Today
August 21, 2023
The companies have developed vaccines for the current dominant strain of COVID, and the Biden administration is getting behind a new booster campaign.
Via
The Motley Fool
Exposures
COVID-19
BioNTech Unusual Options Activity For August 21
August 21, 2023
Via
Benzinga
What's Going On With BioNTech (BNTX) Stock?
August 09, 2023
BioNTech SE - ADR (NASDAQ:BNTX) shares are trading higher by 4.66% to $106.51 Wednesday morning as the stock continues to rebound after falling on Monday.
Via
Benzinga
What's Happening With BioNTech (BNTX) Stock?
August 08, 2023
BioNTech SE - ADR (NASDAQ: BNTX) shares are trading higher by 3.28% to $101.73 Tuesday afternoon as the stock rebounds after falling on Monday.
Via
Benzinga
BioNTech Se (BNTX) Q2 2023 Earnings Call Transcript
August 07, 2023
BNTX earnings call for the period ending June 30, 2023.
Via
The Motley Fool
Why Super League Gaming Are Trading Lower By Around 46%? Here Are Other Stocks Moving In Monday's Mid-Day Session
August 21, 2023
Gainers China SXT Pharmaceuticals, Inc. (NASDAQ: SXTC) shares jumped 120% to $0.33.
Via
Benzinga
Moderna, BioNTech And Other Big Stocks Moving Higher On Monday
August 21, 2023
U.S. stocks traded mixed, with the Dow Jones falling around 150 points on Monday. Here are some big stocks recording gains in today’s session. Genelux Corporation (NASDAQ: GNLX) gained 19.2% to $28.58....
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why BioNTech Stock Was Sinking Today
August 07, 2023
While the waning of the COVID pandemic is a positive development for the world, it's left the German biotech struggling.
Via
The Motley Fool
Why Moderna Stock Sunk Today
August 07, 2023
Moderna, Inc. (NASDAQ: MRNA) shares are trading lower on Monday.
Via
Benzinga
BioNTech Skids As Covid Vaccine-Maker's Sales Plummet And Miss Forecasts
August 07, 2023
The company kept its sales outlook for the year, however.
Via
Investor's Business Daily
Preview: BioNTech's Earnings
August 04, 2023
Via
Benzinga
Covid Vaccine Rally Dashed As Pfizer, Moderna Give Back Gains On Eris' Advance
August 18, 2023
The companies are hoping to launch their updated Covid shots in September.
Via
Investor's Business Daily
Exposures
COVID-19
Moderna, Pfizer's Updated COVID Shot Shows Effectiveness Against 'Eris' Variant In Early Human, Preclinical Studies
August 18, 2023
Moderna Inc (NASDAQ: MRNA) announced that preliminary clinical trial data confirm its updated COVID-19 vaccine for the fall 2023 vaccination season showed a significant boost in neutralizing antibodies...
Via
Benzinga
Exposures
COVID-19
The 3 Most Undervalued Biotech Stocks to Buy Now: August 2023
August 17, 2023
This article points you to three undervalued biotech stocks that have the potential to deliver stellar returns for patient investors.
Via
InvestorPlace
Week In Review: BeiGene And Bristol-Myers Squibb Close BeiGene-Celgene PD-1 Partnership
August 12, 2023
BeiGene and Bristol-Myers Squibb have formally completed the breakup of the BeiGene-Celgene partnership, returning 23.3 million ordinary BeiGene shares to BeiGene. Meanwhile, Gracell Biotechnologies...
Via
Talk Markets
Meet Eris, The COVID Variant Behind A Summer Resurgence In Cases: 3 Drugmakers Prep Fall Booster Shots
August 11, 2023
Via
Benzinga
Exposures
COVID-19
Analyst Ratings for BioNTech
August 01, 2023
Via
Benzinga
Week In Review: BeiGene Options DualityBio ADC In $1.3 Billion Agreement
July 15, 2023
Deals and financings, trials and approvals in the Chinese biotech/biopharma sphere.
Via
Talk Markets
PayPal Unveils USD-Backed Stablecoin, Trucking Firm Yellow Corp Files For Bankruptcy, FDA Approves First Oral Treatment For Postpartum Depression: Today's Top Stories
August 07, 2023
Benzinga
Via
Benzinga
BioNTech Slips Into Quarterly Loss As Q2 Revenue Evaporates, Cuts R&D Spending For FY23
August 07, 2023
BioNTech SE (NASDAQ: BNTX) has reported Q2 revenues of €167.7 million, sharply down from €3.2 billion a year ago
Via
Benzinga
US Stocks Eye Rebound After Big Earnings, But Inflation Data Looms: Analyst Says 3 Factors Can Take S&P 500 Past 4,800
August 07, 2023
US stocks look set for a cautious start as the week's inflation data will likely keep traders on tenterhooks.
Via
Benzinga
Pfizer, Moderna Try To Squeeze Blood From A Stone. Why It Probably Won't Work.
August 03, 2023
The company hopes to launch an updated Covid booster shot this fall. But there are several complications.
Via
Investor's Business Daily
Expert Ratings for BioNTech
July 14, 2023
Via
Benzinga
Analyst Initiates Arcturus: Sees Attractive Growth Trajectory with Vaccine Franchise Despite Competition
July 24, 2023
William Blair analyst Myles Minter has initiated coverage of Arcturus Therapeutics Holdings Inc (NASDAQ: ARCT) with an Outperform rating and a fair
Via
Benzinga
Week In Review: Novartis In $1 Billion Deal For DTx Pharma
July 22, 2023
Novartis signed a $1 billion agreement to acquire DTx Pharma, a preclinical San-Diego company developing siRNA therapies for neuroscience indications. Meanwhile, Zhuhai Biotheus formed a far-reaching...
Via
Talk Markets
Benzinga's Top Ratings Upgrades, Downgrades For July 14, 2023
July 14, 2023
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
54
55
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.